PharmaCytics is a pioneering brand that aims to revolutionize drug treatment, with a focus on enhancing the impact of medication and improving the lives of patients. Founded in 2015 and based in Nijmegen, The Netherlands, PharmaCytics is driven by a strong mission to save and improve lives through innovative prodrug technologies. Led by CEO Han van ‘t Klooster, a seasoned industry professional with over 25 years of experience, PharmaCytics boasts a dedicated team of experts.

Co-founder Gerrit Veeneman, the Chief Scientific Officer, brings extensive drug development experience, specializing in drug delivery and prodrug technologies. The company's expertise lies in developing small molecules and PROTACs, with a particular emphasis on optimizing the transport of medication across cellular membranes. Through their cutting-edge research and development, PharmaCytics is committed to advancing drug delivery methods, ultimately enabling more effective treatment options for patients.

As a leading company in the pharmaceutical industry, PharmaCytics is committed to its vision of transforming drug treatment and improving patient outcomes